Company: NCEL
Filing Date: 2025-07-29
Form Type: F-4/A
Source: 0001213900-25-068765
Chunk: 337

Company: NewcelX Ltd.
Filing Date: 2025-07-29
Form: F-4/A
Chunk 337
---
 to terminate the services of one or more of such persons from time to time and at any time, at his discretion. The CEO may determine the powers and duties of the such persons, as well as their compensation. The current members of the Kadimastem Board will continue to serve as the members of the board of directors of Kadimastem post -Merger. Subject to the approval of Proposal 8 of the NLS Meeting, the board of directors of the combined company shall consist of Mr.Ronen Twito, who is also the nominated Executive Chairman of the board of directors of the combined company, Prof. Michel Revel, Mr.Olivier Samuel, Mr.Eran Iohan, Ms. Liora Oren, Ms. Tammy Galili and Mr.Alexander Zwyer. At each annual ordinary shareholders’ meeting of the combined company, the term of office of all directors serving at that time shall end and new directors shall be elected, by a resolution adopted by a Simple Majority. Directors whose term of office has ended as aforesaid may be re -electedfor an additional term. The board of directors may, by a resolution adopted by the board of directors, appoint an additional director or directors to the company, either to fill a position that has become vacant for any reason or as an additional director or directors, provided that the number of directors does not exceed six. Any vacancy, however created (whether by resignation, departure or otherwise, and/or otherwise with respect to any available position of office in case that the number of directors then in office is less than six (6)), shall continue until the next annual ordinary shareholders’ meeting. Subject to the provisions of Swiss law, the board of directors may delegate its powers to the committees of the board of directors, to its CEO, to an officer in the combined company, or to another person. The delegation of authority may be for a specific matter or for a specific period of time, all at the discretion of the board of directors. Following the Merger, the rights of shareholders and corporate governance standards of Kadimastem prior to the Merger, while under Israeli law and while subject to Kadimastem’s Articles of Association, will differ following the Merger, when the combined company is subject to Swiss law and NLS’s articles of association effective as of the date of the Merger. Several key differences between Israeli and Swiss corporate governance are as follows:

|                          |     | Shareholders’ Rights in Kadimastem in                                                                                  
 Accord